100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
You Searched
₹436.7
Our Recommendation
Miragron 50mg Tablet ER 10s

3,662+ trust this
WHO GMP Certified


WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)

WHO GMP
Certified

15 Days Easy
Returns

Long Expiry
(>8 Months)
Delivery by
In Treatment of Overactive bladder (OAB) symptoms Mirasmart 50 Tablet PR helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control the passing of urine. It also relieves painful, or frequent urination and reduces the urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
Use it as advised by your doctor or check the label for directions before use. Mirasmart 50 Tablet PR can be taken it with or without food, although it's advisable to take it consistently at the same time.
Mirasmart 50 Tablet PR is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. It prevents frequent, urgent or uncontrolled urination.
Caution: It is important to consult your doctor regarding alcohol consumption while taking Mirasmart 50 Tablet PR .
Seek medical advice from your doctor: Mirasmart 50 Tablet PR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Doctor consultation is advised.
Seek medical advice from your doctor: Mirasmart 50 Tablet PR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
SAFE - Mirasmart 50 Tablet PR does not usually affect your ability to drive.
Caution Advised: Mirasmart 50 Tablet PR should be used with caution in patients with severe kidney disease. Dose adjustment of Mirasmart 50 Tablet PR may be needed. Doctor consultation is advised.
Caution Advised: Mirasmart 50 Tablet PR should be used with caution in patients with liver disease. Dose adjustment of Mirasmart 50 Tablet PR may be needed. Doctor consultation is advised. Use of Mirasmart 50 Tablet PR is not recommended in patients with severe liver disease.
If a dose of Mirasmart 50 Tablet PR is missed, take it promptly. However, if your next dose is approaching, skip the missed dose and resume your regular schedule. Avoid doubling the dose.
463, 4 th Floor, RPG HOUSE, Dr. Annie Besant Road, Worli, Mumbai ‚ 400 030. Maharashtra, INDIA
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 924-25
Medscape. Mirabegron (04 Apr. 2019)
Mirabegron. Chertsey, Surrey: Astellas Pharma Ltd.; 2012 (25 Jan. 2019)
Mirabegron. Norman, Oklahoma: Astellas Pharma Technologies, Inc; 2012 (04 Apr. 2019)
National Health Services. Mirabegron (11 Jul. 2023)
CiplaMed. Mirabegron (11 Jul. 2023)
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.